LILIANNA YUEN: Open Payments
NPI 1477059798 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 30 payments from 8 companies in 2025. Trend: 2023 $581 · 2024 $1,123 · 2025 $1,323
Food & beverage: $1,212Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $420 |
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| Vanda Pharmaceuticals Inc. | 6 | $159 |
| Janssen Pharmaceuticals, Inc | 5 | $150 |
| Braeburn Inc. | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| ABBVIE INC. | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: ARISTADA, FANAPT, INVEGA SUSTENNA, BRIXADI, COBENFY, UZEDY, LYBALVI, VRAYLAR.
Industry payments across CA — which companies pay providers there.
